scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0960-0760(97)00136-2 |
P698 | PubMed publication ID | 9569013 |
P2093 | author name string | D Poirier | |
S Auger | |||
P Dionne | |||
P2860 | cites work | The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology | Q28303450 |
Structure of the steroid-binding site of human placental estradiol-17β-dehydrogenase | Q28331163 | ||
Characteristics of human types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition | Q28646522 | ||
Synthesis of 16-(bromoalkyl)-estradiols having inhibitory effect on human placental estradiol 17β-hydroxysteroid dehydrogenase (17-β-HSD type 1) | Q34303094 | ||
Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5'-termini in human placenta | Q34543730 | ||
Characterization of two mRNA species encoding human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17. | Q35169450 | ||
Intracrinology | Q37124969 | ||
A discussion of the roles of oestrogen and progestin in human mammary carcinogenesis | Q37525744 | ||
Alkylation of Estradiol 17beta-Dehydrogenase from Human Placenta with 3-Chloroacetylpyridine - Adenine Dinucleotide | Q39088987 | ||
Comparison of the in vitro conversion of estradiol-17β to estrone of normal and neoplastic human breast tissue | Q39136597 | ||
Do hormones cause breast cancer? | Q40167813 | ||
Synthesis and biological activities of thioether derivatives related to the antiestrogens tamoxifen and ICI 164384. | Q41337772 | ||
8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer | Q41366482 | ||
Preparation of 14,15-secoestra-1,3,5(10)-trien-15-ynes, inhibitors of estradiol dehydrogenase | Q42199022 | ||
The affinity alkylators, 11 alpha-bromoacetoxyprogesterone and estrone 3-bromoacetate, modify a common histidyl residue in the active site of human placental 17 beta,20 alpha-hydroxysteroid dehydrogenase | Q42216100 | ||
Cancer statistics, 1994. | Q43560974 | ||
Distribution of 17 beta-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues | Q48524479 | ||
Expression of human 17β-hydroxysteroid dehydrogenase in mammalian cells | Q67487485 | ||
Human placental estradiol 17 beta-dehydrogenase: evidence for inverted substrate orientation ("wrong-way" binding) at the active site | Q67926252 | ||
Hydrogen bonding in steroidogenesis: studies on new heterocyclic analogs of estrone that inhibit human estradiol 17 beta-dehydrogenase | Q68061527 | ||
Estradiol binding and metabolism in human endometrial hyperplasia and adenocarcinoma | Q68267602 | ||
Mechanism-based inactivation of 17 beta,20 alpha-hydroxysteroid dehydrogenase by an acetylenic secoestradiol | Q68748455 | ||
Trifluoromethylacetylenic alcohols as affinity labels: inactivation of estradiol dehydrogenase by a trifluoromethylacetylenic secostradiol | Q68898162 | ||
Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture | Q68974206 | ||
Metabolism of [3H]oestradiol in vivo by normal breast and tumour tissue in postmenopausal women | Q69496574 | ||
A comparison of the in vivo uptake and metabolism of 3H-oestrone and 3H-oestradiol by normal breast and breast tumour tissues in post-menopausal women | Q69570155 | ||
Affinity labeling of the cofactor-binding site of estradiol 17 beta-dehydrogenase of human placenta by 5'-p-fluorosulfonylbenzoyl adenosine | Q69840136 | ||
17 beta-Hydroxysteroid oxidoreductase: a ubiquitous enzyme. Interconversion of estrone and estradiol-17 beta in BALB/c mouse tissues | Q69845448 | ||
Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women | Q70144075 | ||
The relationship between 17 beta-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue | Q70179417 | ||
Inhibition of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase by antiestrogens | Q70457028 | ||
13C nuclear magnetic resonance study of 17 alpha-substituted estradiols | Q71125482 | ||
Estradiol 17 beta-hydroxysteroid dehydrogenase activity in human breast fibroadenomas | Q72042983 | ||
1H and 13C nuclear magnetic resonance assignments and stereochemistry of N-n-butyl-N-methyl-11-(16'alpha-chloro-3',17'beta- and 17'alpha-dihydroxyestra-1',3',5'(10')-trien-7'alpha-yl) undecanamide | Q72869177 | ||
P433 | issue | 1-2 | |
P921 | main subject | hydroxysteroid | Q2157080 |
P304 | page(s) | 83-90 | |
P577 | publication date | 1998-01-01 | |
P1433 | published in | The Journal of Steroid Biochemistry and Molecular Biology | Q15708871 |
P1476 | title | A 6beta-(thiaheptanamide) derivative of estradiol as inhibitor of 17beta-hydroxysteroid dehydrogenase type 1 | |
P478 | volume | 64 |
Q73215024 | 17Alpha-alkan (or alkyn) amide derivatives of estradiol as inhibitors of steroid-sulfatase activity |
Q31110440 | A multidetachable sulfamate linker successfully used in a solid-phase strategy to generate libraries of sulfamate and phenol derivatives |
Q40841145 | Androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase |
Q31875242 | Inhibitors of type II 17beta-hydroxysteroid dehydrogenase |
Q40888023 | N-Butyl-N-methyl-11-(3'-hydroxy-21', 17'-carbolactone-19'-nor-17'alpha-pregna-1',3', 5'(10')-trien-7'alpha-yl)-undecanamide: an inhibitor of type 2 17beta-hydroxysteroid dehydrogenase that does not have oestrogenic or androgenic activity |
Q41007647 | Overview of a rational approach to design type I 17beta-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: chemical synthesis and biological evaluation |
Q33869561 | Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities |
Q56764589 | Synthesis of a First Estradiol-Adenosine Hybrid Compound |
Q53992034 | Two non-reactive ternary complexes of estrogenic 17beta-hydroxysteroid dehydrogenase: crystallization and preliminary structural analysis. |